What Is It?
A dual GIP/GLP-1 receptor agonist. It activates two hunger-regulating pathways instead of one. Brand name Mounjaro. The most effective weight management compound in clinical trials to date.
How Does It Work?
Activates both GIP and GLP-1 receptors simultaneously. GLP-1 suppresses appetite and slows gastric emptying. GIP improves insulin sensitivity and may enhance fat metabolism. Think of semaglutide as turning down one dial — tirzepatide turns down two.
Primary Benefits
- Superior weight loss vs semaglutide in head-to-head trials
- Blood sugar regulation
- Improved insulin sensitivity
- Cardiovascular benefit signals
Run the Numbers
Calculate your Tirzepatide reconstitution — BAC water volume, syringe units, and draw amounts. Free, no login required.
Open the Tirzepatide Reconstitution Calculator →The Honest Part
- FDA-approved as Mounjaro for type 2 diabetes.
- Being studied for weight management (Zepbound).
- Research compounds may differ from pharmaceutical formulations.
- Common side effects: nausea, diarrhea during titration.
- Always work with a physician.
Research Sources
Verified vendors offering this compound for research purposes. Use the vendor-specific code shown on each card for discounts. We may earn commissions from these links.
Track Tirzepatide in the App
Peptide Manager Pro tracks 100+ compounds with an interactive knowledge graph, dosing calculator, protocol tracker, and AI research chat. Veteran-owned. $4.99/mo founding rate.
Get the App →